Prescribing trends in asthma: A longitudinal observational study

Archives of Disease in Childhood

Volumn 94, Issue 1, 2009, Pages 16-22

  Turner, S ^a,c   Thomas, M ^a   Von Ziegenweidt, J ^b   Price, D ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Respiratory Research Limited   (Norfolk Island)

^c ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ARTICLE; ASTHMA; CHILD; CROSS-SECTIONAL STUDY; DRUG MEGADOSE; GENERAL PRACTITIONER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MONOTHERAPY; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDEMIOLOGIC METHODS; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; MALE; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 58349100253     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.140681     Document Type: Article

References (27)

1. Asher IM, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368:733-43.
2. British Thoracic Society. Scottish Intercollegiate Guideline Network. British guidelines on the management of asthma. Thorax 2003; 58:1-94.
3. GINA Science Committee. Global strategy for asthma prevention and management. 2005. GINA. http://www.ginasthma.com/ (accessed 11 Sep 2008).
4. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159:941-4.
5. Agertoft L. Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000: 343:1064-9.
6. Tonascia J, Adkinson JF, Bender B, et al. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-63.
7. Bacharier LB, Raissy HH, Wilson L, et al. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 2004; 113:1693-9.
8. Covar RA, Leung DY, McCormick D, et al. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 2000; 106:651-9.
9. Visser MJ, van der Veer E, Postma DS, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004; 24:420-5.
10. Ekins-Daukes S, Simpson CR, Helms PJ, et al. Burden of corticosteroids in children with asthma in primary care: retrospective observational study. BMJ 2002; 324:1374.
11. Hawkins G, McMahon AD, Twaddle S, et al. Stepping down inhaled corticosteroids in asthma: randomised controlled trial. BMJ 2003: 326:1115.
12. Drake AJ, Howells RJ, Shield JPH, et al. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002; 324:1081-3.
13. Todd GRD, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002: 87:457-61.
14. Masoi M, Weatherall M, Holt S, et al. Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child 2004; 89:902-7
15. Verona E, Petrov D, Cserhati E, et al. Fluticasone propionate in asthma: a long term dose comparison study. Arch Dis Child 2003; 88:503-9.
16. Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, et al. Decreased Cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate. Arch Dis Child 2004; 89:1055-8
17. Paton J, Jardine E, McNeill E, et al. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child 2006; 91:808-13
18. Sim D, Griffiths A, Armstrong D. et al. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur Respir J 2003; 21:633-6.
19. Szefler S, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109:410-18.
20. Thomas M, Turner S, Leather D, et al. High dose inhaled corticosteroid use in childhood asthma: an observational study. Br J Gen Pract 2006; 56:788-90.
21. Lawson DH, Sherman V, Hollowell J. The General Practice Research Database. O J Med 1998; 91:445-52.
22. Hansel A, Hollowell J, Nichols T, et al. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity survey in general practice (MSGP4|. Thorax 1999; 54:413-19.
23. National Prescribing Centre. Inhaled corticosteroids: children are at risk from high doses. MeReC Extra 27. 2007. http://www.npc.co.uk/MeReC- Extra/2007/no27-2007.htm#INH.
24. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355:2226-35.
25. The British Thoracic Society and others. Guidelines for the management of asthma. Thorax 1993; 48(Suppl):3.
26. Panickar JR, Dodd SR, Smyth RL, et al. Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000. Thorax 2005; 60:1035-8
27. British Thoracic Society. The National Asthma Campaign. The Royal College of Physicians of London. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52(Suppl 1):S1-21.